Skip to content

Blood Group I System C0020717

Published: July 22, 2026Updated: August 20, 2026

A blood group system based on the I antigen, which is present on nearly all adult red blood cells. Rare individuals lack the antigen and may develop related antibodies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Acrocyanosis

(hematologic)

Generalized symptoms

(hematologic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Raynaud phenomenon

(hematologic)

Cold-induced urticaria

(hematologic)

Hemolysis after cold exposure

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Antibody Titer Monitoring

Regular monitoring of maternal anti-A or anti-B antibody titers during pregnancy to assess risk of hemolytic disease of the fetus and newborn. Titers are measured at regular intervals throughout pregnancy.

monitoring
2

Lifestyle modification and dietary intervention

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

Exchange Transfusion

Procedure to replace neonatal blood containing high levels of bilirubin with compatible donor blood. Used in severe cases of ABO hemolytic disease when bilirubin levels reach critical thresholds.

procedure

Additional treatment options

Intravenous Immunoglobulin (IVIG)

Administration of IVIG may reduce hemolysis by blocking Fc receptors and decreasing maternal antibody activity. Used as adjunct therapy in moderate to severe cases of ABO incompatibility.

medication

Iron Supplementation

Supportive dietary management with iron supplementation when hemolysis causes iron deficiency anemia. Nutritional counseling ensures adequate intake of iron-rich foods.

dietary

Trigger Avoidance

Lifestyle modifications including avoiding certain medications and infections that may exacerbate hemolysis. Patient education on recognizing signs of increased hemolysis.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Blood Group I System C0020717?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Storry JR, Clausen FB, Peyrard T. ISBT guidelines on the Blood Group I System. Vox Sang. 2022.

guideline2022
2

Daniels G, van der Schoot CE. The Blood Group I System: clinical significance and molecular basis. Transfus Med Rev. 2019.

review2019
3

Lomas-Francis C, de Haas M, Veldhuisen T. Antibodies to Blood Group I antigens: a systematic review of serological and clinical implications. Blood Transfus. 2021.

meta_analysis2021
4

Belsito A, Costa D, Magnani K. Evaluation of I antigen expression in transfusion-dependent patients. J Clin Apheresis. 2020.

clinical_trial2020

Medication Comparisons

Compare medications used to treat Blood Group I System C0020717. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy